Kathleen Mazor to Atrial Fibrillation
This is a "connection" page, showing publications Kathleen Mazor has written about Atrial Fibrillation.
Connection Strength
0.313
-
Kapoor A, Sadiq H, Patel J, Zhang N, Mazor K, Crawford S, Chen Z, Gurwitz J, McManus D, Hanchate A. Disparities in Anticoagulation Use by Race and Ethnicity in Long-Term Care Residents With Atrial Fibrillation. J Am Heart Assoc. 2021 12 07; 10(23):e023428.
Score: 0.105
-
Kapoor A, Amroze A, Vakil F, Crawford S, Der J, Mathew J, Alper E, Yogaratnam D, Javed S, Elhag R, Lin A, Narayanan S, Bartlett D, Nagy A, Shagoury BK, Fischer MA, Mazor KM, Saczynski JS, Ashburner JM, Lopes R, McManus DD. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e005871.
Score: 0.093
-
Amroze A, Mazor K, Crawford S, O'Day K, McManus DD, Kapoor A. Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study. J Thromb Thrombolysis. 2019 Nov; 48(4):629-637.
Score: 0.091
-
Hoque L, Amroze A, Gilvaz V, Abraham S, Lal A, Mishra A, Crawford S, Mazor K, McManus DD, Kapoor A. Assessing Anticoagulation Management and Shared Decision-Making Documentation From Providers Participating in the SUPPORT-AF II Study. J Contin Educ Health Prof. 2020; 40(2):76-80.
Score: 0.023